- Report
- October 2023
- 181 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- August 2023
- 112 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- July 2023
- 110 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- January 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- January 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- August 2023
- 145 Pages
Global
From €3040EUR$3,150USD£2,608GBP
- Report
- December 2023
- 265 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- September 2023
- 114 Pages
Global
From €2847EUR$2,950USD£2,442GBP
- Report
- September 2023
- 194 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- November 2023
- 29 Pages
United States
€2413EUR$2,500USD£2,070GBP
- Report
- September 2023
- 101 Pages
North America
From €2847EUR$2,950USD£2,442GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2847EUR$2,950USD£2,442GBP
- Report
- September 2023
- 112 Pages
Europe
From €3330EUR$3,450USD£2,856GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3330EUR$3,450USD£2,856GBP
- Report
- July 2020
- 269 Pages
Global
From €3375EUR$3,497USD£2,895GBP
- Report
- April 2020
- 248 Pages
Global
From €4729EUR$4,899USD£4,056GBP
- Report
- November 2019
- 403 Pages
Global
From €4342EUR$4,499USD£3,725GBP
- Report
- October 2022
- 194 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- November 2020
- 217 Pages
Global
From €3861EUR$4,000USD£3,312GBP
- Report
- April 2020
- 182 Pages
Global
From €3861EUR$4,000USD£3,312GBP
The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more